Compare
Cavitation Technologies, Inc. vs RYTHM, Inc. vs Mission Produce, Inc. vs BrightView Holdings, Inc.
| Latest fiscal year | Cavitation Technologies, Inc. CVAT | RYTHM, Inc. RYM | Mission Produce, Inc. AVO | BrightView Holdings, Inc. BV |
|---|---|---|---|---|
| Year ended | 2026-06-30 | 2025-12-31 | 2025-10-31 | 2026-09-30 |
| Revenue | $3.0K | $17.28M | $1.39B | $2.71B |
| Revenue growth (YoY) | -98.5% | n/m | +12.7% | +1.5% |
| Gross margin | 100.0% | 59.0% | 11.6% | 20.4% |
| Operating margin | n/m | -187.1% | 4.7% | 2.8% |
| Net margin | n/m | -192.4% | 2.7% | 0.0% |
| Net income | -$1.40M | -$33.26M | $37.70M | $1.00M |
| EPS (Diluted) | $0.00 | -$16.68 | $0.53 | -$0.37 |
| Operating cash flow | -$755.0K | -$23.54M | $88.60M | $184.70M |
| Free cash flow | n/a | n/a | $37.20M | -$40.30M |
| Cash & equivalents | $17.0K | $32.20M | $64.80M | $3.60M |
| Total assets | $45.0K | $106.68M | $983.00M | $3.43B |
| Total liabilities | $738.0K | $93.66M | $363.10M | $1.69B |
| Shareholders' equity | -$693.0K | $13.02M | $587.30M | $1.23B |
| Return on year-end equity | n/a | -255.4% | 6.4% | 0.1% |
| Shares outstanding | 317.22M | 2.15M | 70.57M | 91.70M |
Revenue, most recent five fiscal years
| Fiscal year | Cavitation Technologies, Inc. | RYTHM, Inc. | Mission Produce, Inc. | BrightView Holdings, Inc. |
|---|---|---|---|---|
| Latest | $3.0K Ended 2026-06-30 | $17.28M Ended 2025-12-31 | $1.39B Ended 2025-10-31 | $2.71B Ended 2026-09-30 |
| 1 year earlier | $203.0K Ended 2025-06-30 | $18.0K Ended 2024-12-31 | $1.23B Ended 2024-10-31 | $2.67B Ended 2025-09-30 |
| 2 years earlier | $1.36M Ended 2024-06-30 | $15.14M Ended 2023-12-31 | $953.90M Ended 2023-10-31 | $2.77B Ended 2024-09-30 |
| 3 years earlier | $433.0K Ended 2023-06-30 | $58.26M Ended 2022-12-31 | $1.05B Ended 2022-10-31 | $2.82B Ended 2023-09-30 |
| 4 years earlier | n/a | $59.86M Ended 2021-12-31 | $891.70M Ended 2021-10-31 | $2.77B Ended 2022-09-30 |